drugset / Trial / NCT03216473
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical study evaluates the efficacy and safety of Neuronox compared with Botox in adults with essential blepharospasm.
Timeline
- Start
- 2016-05-25
- Primary completion
- 2017-03-17
- Completion
- 2017-07-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 100 iu | — |
| Subject | Neuronox | Protein / enzyme biologic | 100 iu | — |